Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel S Freeman

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
European Urology|March 11, 2019
The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival ProbabilityJaegil Kim, David Kwiatkowski, David J McConkey, et al.
STAR Protocols|February 28, 2023
Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purityAnna L K Gonye, Thomas J LaSalle, Samuel S Freeman, et al.
Nature Communications|July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVectorNicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Identification and characterization of an alternative cancer-derived PD-L1 splice variantNadia B Hassounah, Venkat S Malladi, Yi Huang, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Metagenomic Characterization of Microbial Communities <i>In Situ</i> Within the Deeper Layers of the Ileum in Crohn's DiseaseChandra Sekhar Pedamallu, Ami S Bhatt, Susan Bullman, et al.
Cancer Immunology Research|November 24, 2020
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1Rupal S Bhatt, Abdulla Berjis, Julie C Konge, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancerSohrab Salehi, Emily E Stroobant, Hannah Lees, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast CancerDaniel G Stover, Heather A Parsons, Gavin Ha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Graydon Moorhead, Robin Park, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
European Urology|March 11, 2019
The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival ProbabilityJaegil Kim, David Kwiatkowski, David J McConkey, et al.
STAR Protocols|February 28, 2023
Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purityAnna L K Gonye, Thomas J LaSalle, Samuel S Freeman, et al.
Nature Communications|July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVectorNicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2018
Identification and characterization of an alternative cancer-derived PD-L1 splice variantNadia B Hassounah, Venkat S Malladi, Yi Huang, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Metagenomic Characterization of Microbial Communities <i>In Situ</i> Within the Deeper Layers of the Ileum in Crohn's DiseaseChandra Sekhar Pedamallu, Ami S Bhatt, Susan Bullman, et al.
Cancer Immunology Research|November 24, 2020
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1Rupal S Bhatt, Abdulla Berjis, Julie C Konge, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancerSohrab Salehi, Emily E Stroobant, Hannah Lees, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast CancerDaniel G Stover, Heather A Parsons, Gavin Ha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Graydon Moorhead, Robin Park, et al.
Pageof 4